SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities.

El Safadi, D; Hitchins, L; Howard, A; Aley, P; Bowman, J; Bertran, M; Collins, A; Colin-Jones, R; Elterish, F; Fry, NK; et al. El Safadi, D; Hitchins, L; Howard, A; Aley, P; Bowman, J; Bertran, M; Collins, A; Colin-Jones, R; Elterish, F; Fry, NK; Gordon, SB; Gould, K; Hinds, J; Horn, E; Hyder-Wright, A; Kandasamy, R; Ladhani, S; Litt, D; Mitsi, E; Murphy, A; Pollard, AJ; Plested, E; Pojar, S; Ratcliffe, H; Robertson, MC; Robinson, H; Snape, MD; Solórzano, C; Voysey, M; Begier, E; Catusse, J; Lahuerta, M; Theilacker, C; Gessner, BD; Tiley, KS; Ferreira, DM (2024) Pneumococcal carriage and disease in adults in England 2011-2019: the importance of adults as a reservoir for pneumococcus in communities. J Infect Dis. ISSN 1537-6613 https://doi.org/10.1093/infdis/jiae351
SGUL Authors: Hinds, Jason Gould, Katherine Ann

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (613kB) | Preview
[img] Archive (ZIP) (Supplementary data) Supplemental Material
Download (184kB)

Abstract

BACKGROUND: Pneumococcal carriage in children has been extensively studied, but carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is less understood. METHODS: Nasal wash samples from adults without close contact with young children (Liverpool, UK), 2011-2019, were cultured, and culture-negative samples tested by PCR. Pneumococcal carriage in adults 18-44 years was compared with carriage among PCV-vaccinated children 13-48 months (nasopharyngeal swabs, Thames Valley, UK) and IPD data for England for the same ages for 2014-2019. Age-group specific serotype invasiveness was calculated and used with national IPD data to estimate carriage serotype distributions for adults aged 65+ years. RESULTS: In total 98 isolates (97 carriers) were identified from 1,631 adults aged 18+ years (age and sex standardized carriage prevalence 6.4%), with only three identified solely by PCR. Despite different carriage and IPD serotype distributions between adults and children, serotype invasiveness was highly correlated (R=0.9). Serotypes 3, 37 and 8 represented a higher proportion of adult carriage than expected from direct low-level transmission from children to adults. The predicted carriage serotype distributions for 65+ years aligned more closely with the carriage serotype distribution for young adults than young children. CONCLUSIONS: The nasal wash technique is highly sensitive; additional benefit of PCR is limited. Comparison of carriage serotype distributions suggests some serotypes may be circulating preferentially within these specific young adults. Our data suggest that for some serotypes carried by adults 65+ years, other adults may be an important reservoir for transmission. Age groups such as older children should also be considered.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: adults, carriage, children, invasive pneumococcal disease, pneumococcal, transmission, 06 Biological Sciences, 11 Medical and Health Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Academic Structure > REF 2021 user group
Journal or Publication Title: J Infect Dis
ISSN: 1537-6613
Language: eng
Dates:
DateEvent
16 July 2024Published Online
9 July 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDPfizerhttp://dx.doi.org/10.13039/100004319
UNSPECIFIEDNIHR Oxford Biomedical Research Centrehttp://dx.doi.org/10.13039/501100013373
UNSPECIFIEDNIHR Clinical Research Network Thames Valley and South Midlandshttp://dx.doi.org/10.13039/501100012091
PubMed ID: 39013016
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116698
Publisher's version: https://doi.org/10.1093/infdis/jiae351

Actions (login required)

Edit Item Edit Item